| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 69 |
| 1 | ASPIRIN | 23 |
| 2 | PALBOCICLIB | 22 |
| 3 | ASPIRIN 325 MG | 21 |
| 4 | ASPIRIN 81 MG | 21 |
| 5 | ASPIRIN TABLET 325MG | 21 |
| 6 | ERGOCALCIFEROL | 19 |
| 7 | RITUXIMAB | 19 |
| 8 | CYCLOPHOSPHAMIDE | 18 |
| 9 | DEXAMETHASONE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCICLOVINE F-18 | 9 | 0.1475 |
| 1 | FLORBETAPIR F 18 | 1 | 0.0244 |
| 2 | FLUDEOXYGLUCOSE F-18 | 2 | 0.0155 |
| 3 | RUBIDIUM CHLORIDE RB-82 | 1 | 0.0110 |
| 4 | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | 1 | 0.0084 |
| 5 | TROLAMINE SALICYLATE | 1 | 0.0066 |
| 6 | TISOTUMAB VEDOTIN | 1 | 0.0061 |
| 7 | NIRAPARIB | 69 | 0.0047 |
| 8 | PENCICLOVIR | 1 | 0.0031 |
| 9 | SODIUM FLUORIDE F18 | 1 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 69 |
| 1 | Kinase Inhibitor [EPC] | 51 |
| 2 | Corticosteroid [EPC] | 38 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| 5 | Benzodiazepine [EPC] | 24 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 7 | Alkylating Drug [EPC] | 21 |
| 8 | Aromatase Inhibitor [EPC] | 21 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radioactive Diagnostic Agent [EPC] | 12 | 0.0093 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 69 | 0.0028 |
| 2 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 4 | 0.0017 |
| 3 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0007 |
| 4 | Estrogen Receptor Antagonist [EPC] | 12 | 0.0006 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0003 |
| 6 | Chloride Channel Activator [EPC] | 2 | 0.0003 |
| 7 | Aromatase Inhibitor [EPC] | 21 | 0.0003 |
| 8 | Bismuth [EPC] | 1 | 0.0002 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0002 |